Cultivation Capital leads $1.3 mln funding in Euclises Pharmaceuticals
Cultivation Capital has led a $1.3 million Series A funding in Euclises Pharmaceuticals, a biotech company developing cancer treatments. Other participants in the funding include BioGenerator, Missouri Technology Corporation, ABC Laboratories, the St. Louis County Port Authority's Helix Fund and the St. Louis Arch Angels.
10 September 2014•2 mins read
